Oxygen Plant Project Report: Industry Trends, Plant Setup, Machinery, Raw Materials, Investment Opportunities, Cost and Revenue

Note: The regulatory items below outline the typical compliance architecture for this project type. Specific BIS / IS standard numbers, licence thresholds, GST HSN codes, and scheme rates referenced should be verified with the issuing authority (see References & primary sources at the bottom of this page). KAMRIT's compliance team confirms each item against current notifications during project engagement.

Oxygen plant projects in India take a baseline set of central and state approvals layered with the sector-specific BIS / EIA / PLI overlay. For ₹6.5 crore - ₹112 crore project size, the touchpoints KAMRIT covers are:

• Import-Export Code (IEC) and DGFT Star Export House registration for export-led units
• EPF (20+ employees), ESI (10+ employees and ₹21k wage threshold), PT, Shops Act
• Factory licence under the Factories Act 1948 plus state Boiler Inspectorate approval
• State Pollution Control Board CTE and CTO (Red/Orange/Green/White by category)
• BIS certification for products on the mandatory certification list
• Environmental clearance under EIA 2006 (Schedule 8, project capacity threshold)

KAMRIT files and tracks every one of these approvals end-to-end in the Tier 3 Execution Partnership, including dossier preparation, regulator interaction, fee remittance, and the renewal calendar through year three of operations.

<p>The oxygen plant market in India spans multiple high-demand sectors. The healthcare sector remains the most critical end-user, driven by hospitals, clinics, and the growing home healthcare segment. Approximately 75 percent of patients with chronic respiratory diseases preferred home healthcare settings, fueling demand for smaller oxygen generation systems.

The industrial sector demands oxygen for steel manufacturing, chemical processing, welding, and cutting operations. North India dominates the regional medical and bulk oxygen market share, driven by high population density across Uttar Pradesh, Bihar, Delhi, Punjab, and Rajasthan. West India exhibits high consumption driven by industrial clusters and healthcare demand concentrated in Maharashtra and Gujarat.</p><p>The India bulk oxygen market is valued at USD 1.09 billion with a base year of 2025 and an active forecast starting 2026, while the India liquid oxygen market is valued at USD 198.4 million in 2025.

The global industrial oxygen market was valued at USD 71.45 billion in 2025, and the global high-purity oxygen market reached USD 30.2 billion in the same year. Institutional and industrial buyers in India increasingly prefer customer-owned oxygen generation plants over relying exclusively on transported gas supply to reduce delivery risks and secure operational control, signaling a structural shift in procurement preferences across sectors.</p>

Project-specific demand drivers

• PLI scheme allocations
• Import substitution policy
• Localisation under PM Gati Shakti
• China+1 supply chain redirection
• Export-led demand to MENA and Africa

<p>Two primary process technologies dominate the Indian oxygen plant market. Cryogenic Air Separation Units account for roughly 31 percent of the market and specialize in high-volume production up to thousands of tons per day, delivering high-purity oxygen ranging from 99.5 percent to greater than or equal to 99.999 percent electronic grade. Pressure Swing Adsorption technology dominates decentralized on-site generation, holding approximately 45 percent market share, and is utilized for medium-scale industrial and medical applications.

Vacuum Pressure Swing Adsorption serves as an alternative for larger on-site generation needs, while portable and semi-portable PSA units are gaining adoption for smaller hospital and home care settings.</p><p>Capital expenditure for oxygen plants varies significantly by scale and technology. Small-scale capacity plants of approximately 6 cubic meters per hour or 24 cylinders per day require capital investment between INR 20 Lakh and INR 35 Lakh. Medium-scale capacity of approximately 40 cubic meters per hour or 250 cylinders per day requires approximately INR 1.25 Crore.

Large-scale capacity plants reaching up to 200 normal cubic meters per hour demand capital investment of up to INR 4 Crore. Overall CapEx ranges from INR 15 Lakh to INR 4 Crore depending on scale, technology, and automation levels. Specific PSA unit pricing from Cistron Systems and Absstem includes a 50 LPM PSA oxygen generator for small hospitals and clinics of 15 to 30 beds at INR 12 lakh to INR 18 lakh, a 100 LPM PSA oxygen generator for medium hospitals of 30 to 60 beds at INR 25 lakh to INR 35 lakh, and a 200 LPM PSA oxygen generator for large hospitals of 60 to 120 beds at INR 30 lakh to INR 40 lakh.</p><p>Operating expenses are dominated by utilities.

Atmospheric air as primary raw material, utilized via cryogenic distillation or pressure swing adsorption, accounts for 30 percent to 40 percent of operational expenses. Electricity represents 45 percent to 55 percent of total OpEx, with power consumption accounting for over 65 percent of an ASU's operating costs. Energy performance optimization targets specific power consumption measured in kilowatt-hours per normal cubic meter, achieved through high-efficiency multi-stage air compression and tight plate-fin heat exchanger integration.</p>

The project's CapEx range of Rs. 6.5 crore to Rs. 112 crore warrants differentiated financing structures. For mid-scale PSA/VSA facilities (Rs. 10-30 crore), KAMRIT recommends a debt-equity ratio of 65:35 drawing from the following sources.

Term loans from SIDBI (up to Rs. 15 crore at 8.5-10.5% interest under the SIDBI Stand-Up India programme) and PSB consortiums including SBI and Bank of Baroda offer competitive rates for MSME-classified enterprises. CGTMSE guarantee coverage of up to 85% of the loan amount reduces collateral requirements, enabling promoter contribution as low as 20% of project cost. State MSME schemes in Gujarat (MGVCL Subsidy), Maharashtra (Maharashtra State Innovation Startup Policy), and Tamil Nadu (TANSIIC funding) provide capital subsidy of 10-15% of fixed capital investment, directly reducing equity requirement.

For large-scale ASU projects exceeding Rs. 50 crore, ICICI Bank and HDFC Bank's corporate banking arms offer project finance structures at leverage of 70:30 with 7-10 year tenor. IREDA financing applies for oxygen plants serving renewable energy manufacturing clusters, with interest rates starting at 6.5% for green manufacturing classifications. Axis Bank's equipment finance vertical provides machinery-specific financing for imported gas separation equipment with deferred LC payment structures.

Working capital requirements of Rs. 2.5-4.0 crore (approximately 45-60 days of operating expense) are recommended through revolving credit facilities from the consortium bank, secured against inventory of filled cylinders and receivables from established industrial customers. Export credit facilities from EXIM Bank support international sales contracts to MENA buyers with letters of credit confirmation structures.

PLI benefits under the Production Linked Incentive Scheme for Pharmaceuticals and Bulk Drugs (allocation Rs. 6,940 crore for FY2021-2025) may apply if the project supplies oxygen to domestic API manufacturing units, providing 5-8% incentive on incremental sales over the baseline year.

<p>Several risks and bottlenecks warrant careful assessment for oxygen plant investors in India. Energy cost volatility poses a significant operational risk, as electricity accounts for 45 percent to 55 percent of total operating expenses and over 65 percent of Air Separation Unit operating costs. India's power tariff structure and supply reliability directly impact plant-level economics, particularly for energy-intensive cryogenic ASU operations.

Regulatory compliance requirements are extensive, spanning CDSCO licensing under the Medical Devices Rules, 2017, adherence to Indian Pharmacopoeia 2018 purity standards of greater than or equal to 99.0 percent for medical-grade oxygen, explosives and safety certification from PESO, and ongoing compliance with the Drugs and Cosmetics Act, 1940 and Factories Act, 1948. GST rate classifications can also impact pricing, with PSA medical oxygen generation plants taxed at 18 percent.</p><p>Human resource constraints present operational challenges. Continuous 24/7 direct-piping or cylinder-filling operations require a minimum of one certified or qualified electrical, mechanical, or biomedical technician present on-site at all times per operational shift, with cylinder-filling configurations requiring an additional one to two balloters per shift.

Skilled technician availability in tier-2 and tier-3 locations where many new plants are being installed may constrain operations. Market competition from established multinational players with deep capital reserves and nationwide distribution networks creates barriers for new entrants. Import dependence on certain components and plant equipment remains a risk factor, as evidenced by India's 2024 oxygen product imports under code 280440 valued at USD 769.97 thousand.

Additionally, the pre-COVID baseline of only 1,000 MT per day designated for medical use out of 6,900 MT total production highlighted the sector's vulnerability to demand surges, suggesting that capacity planning must account for demand elasticity beyond steady-state industrial consumption.</p>